BPGbio
BPGbio believe that a comprehensive understanding of patient biology is key to unlocking insights catalyzing drug discovery for some of our most challenging and debilitating diseases. That’s why they are reimagining how unbiased patient biological data can be utilized to speed up and de-risk the process of drug discovery across oncology, neurology and rare diseases.
Latest Content
Industry Insight
Collaboration Aims To Advance E2-Based Targeted Protein Degradation
Vivek Vishnudas discusses the unique advantages of E2-based TPD and its potential to revolutionize treatment for challenging diseases.
Article
Don’t Believe the Hype: Promoting AI Ethics and Principles
In this opinion piece, Dr. Niven R. Narain discusses the importance of promoting AI ethics in biotech and outlines how this can be achieved.
Advertisement
